Thieme E-Books & E-Journals -
Back
Synfacts 2023; 19(06): 0615
DOI: 10.1055/s-0042-1752682
Innovative Drug Discovery and Development

Discovery of a Selective pan-FGFR Inhibitor Approved for Treatment of Cholangiocarcinoma

Contributor(s):
Antonia F. Stepan (Roche)
,
Danica A. Rankic (Pfizer)